Houlihan Lokey, Inc. (NYSE: HLI)

Houlihan Lokey, Inc., recognized by its stock symbol HLI, operates as a prominent global independent investment bank, specializing in mergers and acquisitions (M&A), capital markets, financial restructurings, and financial and valuation advisory. Established in 1972, the company has expanded its footprint with offices in the Americas, Europe, Asia, Australia, and the Middle East.

The company's primary business activities encompass Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance practice, led by 223 Managing Directors, offers M&A and capital markets advisory services, employing a collaborative and interdisciplinary approach to deliver extensive industry and product expertise and global reach. This practice competes with boutique firms focused on specific industries or geographies, as well as other global independent investment banks and bulge-bracket firms.

Houlihan Lokey's Financial Restructuring practice, led by 54 Managing Directors, provides advisory services to companies experiencing financial distress or reorganization. Known for its work on complex restructurings, the practice has built a reputation as the go-to advisor for many large and intricate restructurings, offering knowledge, experience, and creativity to navigate challenging situations.

The Financial and Valuation Advisory practice, led by 39 Managing Directors, offers financial opinions, valuations, and financial consulting services to clients. This practice has gained recognition as a thought-leader in the field of valuation, with its professionals producing influential studies and publications respected throughout the financial industry.

Revenue generation for Houlihan Lokey occurs through these primary business practices. The company's Corporate Finance practice focuses on M&A and capital markets advisory services, with prominent clients such as leading global technology companies and major healthcare providers. The Financial Restructuring practice has advised on significant restructurings, including those of major automotive manufacturers and energy companies. The Financial and Valuation Advisory practice has been instrumental in high-profile valuations, including those of leading technology companies and major healthcare providers.

Houlihan Lokey maintains a strong position within the industry, competing with firms like Jefferies LLC, Lazard Ltd, Moelis & Company, NM Rothschild & Sons Limited, Piper Sandler Companies, Robert W. Baird & Co. Incorporated, Stifel Financial Corp., William Blair & Company, L.L.C., and bulge-bracket investment banking firms. The company's competitive advantages include deep sector expertise, substantial senior banker involvement, and robust financial sponsor relationships, providing compelling value for clients.

The company's human capital is a significant driver of success, emphasizing broad employee ownership, which aligns employee and shareholder incentives. Additionally, Houlihan Lokey invests considerable time and resources in training and mentoring employees, ensuring they reach their highest potential.